Van der Velden VHJ - Search Results

1

The KMT2A recombinome of acute leukemias in 2023.

Meyer C, Larghero P, Almeida Lopes B, Burmeister T, Gröger D, Sutton R, Venn NC, Cazzaniga G, Corral Abascal L, Tsaur G, Fechina L, Emerenciano M, Pombo-de-Oliveira MS, Lund-Aho T, Lundán T, Montonen M, Juvonen V, Zuna J, Trka J, Ballerini P, Lapillonne H, Van der Velden VHJ, Sonneveld E, Delabesse E, de Matos RRC, Silva MLM, Bomken S, Katsibardi K, Keernik M, Grardel N, Mason J, Price R, Kim J, Eckert C, Lo Nigro L, Bueno C, Menendez P, Zur Stadt U, Gameiro P, Sedék L, Szczepański T, Bidet A, Marcu V, Shichrur K, Izraeli S, Madsen HO, Schäfer BW, Kubetzko S, Kim R, Clappier E, Trautmann H, Brüggemann M, Archer P, Hancock J, Alten J, Möricke A, Stanulla M, Lentes J, Bergmann AK, Strehl S, Köhrer S, Nebral K, Dworzak MN, Haas OA, Arfeuille C, Caye-Eude A, Cavé H, Marschalek R. Meyer C, et al. Among authors: van der velden vhj. Leukemia. 2023 May;37(5):988-1005. doi: 10.1038/s41375-023-01877-1. Epub 2023 Apr 5. Leukemia. 2023. PMID: 37019990 Free PMC article.

2

Clearance of maternal leukaemic cells in a neonate.

van der Velden VH, Willemse MJ, Mulder MF, Szczepański T, Langerak AW, Wijkhuijs JM, van Dongen JJ. van der Velden VH, et al. Br J Haematol. 2001 Jul;114(1):104-6. doi: 10.1046/j.1365-2141.2001.02914.x. Br J Haematol. 2001. PMID: 11472352 Free article.

3

T-lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies.

van Wering ER, van der Linden-Schrever BE, van der Velden VH, Szczepański T, van Dongen JJ. van Wering ER, et al. Leukemia. 2001 Aug;15(8):1301-3. doi: 10.1038/sj.leu.2402184. Leukemia. 2001. PMID: 11480575 No abstract available.

4

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.

Boeckx N, Willemse MJ, Szczepanski T, van der Velden VH, Langerak AW, Vandekerckhove P, van Dongen JJ. Boeckx N, et al. Leukemia. 2002 Mar;16(3):368-75. doi: 10.1038/sj.leu.2402387. Leukemia. 2002. PMID: 11896540

5

Minimal residual disease in leukaemia patients.

Szczepański T, Orfão A, van der Velden VH, San Miguel JF, van Dongen JJ. Szczepański T, et al. Lancet Oncol. 2001 Jul;2(7):409-17. doi: 10.1016/s1470-2045(00)00418-6. Lancet Oncol. 2001. PMID: 11905735 Review.

6

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.

van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956

7

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.

Szczepański T, Flohr T, van der Velden VH, Bartram CR, van Dongen JJ. Szczepański T, et al. Best Pract Res Clin Haematol. 2002 Mar;15(1):37-57. doi: 10.1053/beha.2002.0184. Best Pract Res Clin Haematol. 2002. PMID: 11987915 Review.

8

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.

van der Velden VH, Wijkhuijs JM, Jacobs DC, van Wering ER, van Dongen JJ. van der Velden VH, et al. Leukemia. 2002 Jul;16(7):1372-80. doi: 10.1038/sj.leu.2402515. Leukemia. 2002. PMID: 12094263

9

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL.

van der Velden VH, Jacobs DC, Wijkhuijs AJ, Comans-Bitter WM, Willemse MJ, Hählen K, Kamps WA, van Wering ER, van Dongen JJ. van der Velden VH, et al. Leukemia. 2002 Aug;16(8):1432-6. doi: 10.1038/sj.leu.2402636. Leukemia. 2002. PMID: 12145681

10

Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin.

Moppett J, van der Velden VH, Wijkhuijs AJ, Hancock J, van Dongen JJ, Goulden N. Moppett J, et al. Leukemia. 2003 Jan;17(1):268-70. doi: 10.1038/sj.leu.2402751. Leukemia. 2003. PMID: 12529693 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page